MYC and breast cancer: SUMO E1 enzyme is involved in Myc-driven tumors; SAE2 is required in supporting Myc-dependent carcinogenesis, and its depletion, that triggers mitotic defects, reduces Myc-dependent BC (Kessler et al., 2012).